Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · Louisiana · Title 22 — Insurance

RS 22:1059.7

306 words·~1 min read·/la/title-22/22-2634

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

RS 22:1059.7
NOTE: Section 1059.7 eff. upon appropriation of monies. See Acts 2025, No. 367.
§1059.7. Required coverage for amino acid-based elemental formulas
A. A health insurance issuer offering health coverage plans in this state that provides benefits for maternity services shall provide coverage for amino acid-based elemental formulas, regardless of the formula delivery method, to treat a child aged two years or younger. Coverage applies pursuant to this Section if the child has been diagnosed by a board-certified allergist or board-certified gastroenterologist and the treating physician issues a written order stating that the amino acid-based elemental formula is medically necessary to treat the child for any of the following:
(1)Immunoglobulin E and non-immunoglobulin E mediated allergies to multiple food proteins.
(2)Severe food protein-induced enterocolitis syndrome.
(3)Eosinophilic disorders, as evidenced by the results of a biopsy.
(4)Impaired absorption of nutrients caused by disorders affecting the absorptive surface, functional length, and motility of the gastrointestinal tract.
B. Coverage pursuant to this Section may be subject to annual deductibles, coinsurance, and copayments consistent with those established under the health coverage plan.
C.(1) A health coverage plan shall provide coverage pursuant to this Section on a basis no less favorable than the basis on which prescription drugs and other medications and related services are covered by the plan, and to the same extent that the plan provides coverage for drugs that are available only on the orders of a physician.
(2)A utilization review agent acting on behalf of a health coverage plan issuer may review a treating physician's determination of the medical necessity of the use of an amino acid-based elemental formula for the treatment of a covered infant or child who is diagnosed with a disease or disorder listed in Subsection A of this Section.
Acts 2025, No. 367, §1, eff. See Act.
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.